Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Abstract:
With the rapid rise in the use of GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) for type 2 diabetes and obesity, clinicians are seeing a paradigm shift in treatment possibilities — but not without challenges. While the pharmacological effectiveness of these medications is well documented, real-world outcomes are often hindered by poor adherence, unmanaged expectations, and lack of behavioral support.
This session explores a structured patient coaching model that fills the critical gap between clinical guidance and long-term success. Drawing from over two decades of personal experience managing type 2 diabetes, and a professional background as a pharmacist and coach, Dr. Keith Hersey presents actionable strategies to help patients integrate GLP-1 therapies into their daily lives.
Topics covered include:
- Common barriers to success among GLP-1 patients
- Best practices for side effect management and dose adjustments
- Lifestyle strategies that reinforce medication effectiveness (nutrition, movement, sleep)
- Coaching frameworks that promote accountability, mindset shifts, and sustainable habits
- How healthcare providers can collaborate with coaches to improve patient outcomes
This presentation is ideal for endocrinologists, diabetes educators, pharmacists, and primary care teams seeking to bridge the gap between medication and behavioral change. The goal: empower providers with tools to guide patients toward health transformation, not just weight loss or glucose control.
